These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 35853557)

  • 1. C-Reactive protein and the kynurenic acid to quinolinic acid ratio are independently associated with white matter integrity in major depressive disorder.
    Zheng H; Teague TK; Yeh FC; Burrows K; Figueroa-Hall LK; Aupperle RL; Khalsa SS; Paulus MP; Savitz J
    Brain Behav Immun; 2022 Oct; 105():180-189. PubMed ID: 35853557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
    Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
    Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kynurenic acid is reduced in females and oral contraceptive users: Implications for depression.
    Meier TB; Drevets WC; Teague TK; Wurfel BE; Mueller SC; Bodurka J; Dantzer R; Savitz J
    Brain Behav Immun; 2018 Jan; 67():59-64. PubMed ID: 28867283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression.
    Young KD; Drevets WC; Dantzer R; Teague TK; Bodurka J; Savitz J
    Brain Behav Immun; 2016 Aug; 56():335-42. PubMed ID: 27091600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-time fMRI neurofeedback amygdala training may influence kynurenine pathway metabolism in major depressive disorder.
    Tsuchiyagaito A; Smith JL; El-Sabbagh N; Zotev V; Misaki M; Al Zoubi O; Kent Teague T; Paulus MP; Bodurka J; Savitz J
    Neuroimage Clin; 2021; 29():102559. PubMed ID: 33516062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes.
    Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V
    Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder.
    Savitz J; Drevets WC; Wurfel BE; Ford BN; Bellgowan PS; Victor TA; Bodurka J; Teague TK; Dantzer R
    Brain Behav Immun; 2015 May; 46():55-9. PubMed ID: 25686798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the kynurenine pathway is associated with striatal volume in major depressive disorder.
    Savitz J; Dantzer R; Meier TB; Wurfel BE; Victor TA; McIntosh SA; Ford BN; Morris HM; Bodurka J; Teague TK; Drevets WC
    Psychoneuroendocrinology; 2015 Dec; 62():54-8. PubMed ID: 26232650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder.
    Savitz J; Drevets WC; Smith CM; Victor TA; Wurfel BE; Bellgowan PS; Bodurka J; Teague TK; Dantzer R
    Neuropsychopharmacology; 2015 Jan; 40(2):463-71. PubMed ID: 25074636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep disturbance and kynurenine metabolism in depression.
    Cho HJ; Savitz J; Dantzer R; Teague TK; Drevets WC; Irwin MR
    J Psychosom Res; 2017 Aug; 99():1-7. PubMed ID: 28712413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum kynurenic acid is reduced in affective psychosis.
    Wurfel BE; Drevets WC; Bliss SA; McMillin JR; Suzuki H; Ford BN; Morris HM; Teague TK; Dantzer R; Savitz JB
    Transl Psychiatry; 2017 May; 7(5):e1115. PubMed ID: 28463241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder.
    Savitz J; Dantzer R; Wurfel BE; Victor TA; Ford BN; Bodurka J; Bellgowan PS; Teague TK; Drevets WC
    Psychoneuroendocrinology; 2015 Feb; 52():200-11. PubMed ID: 25486577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral and central kynurenine pathway abnormalities in major depression.
    Paul ER; Schwieler L; Erhardt S; Boda S; Trepci A; Kämpe R; Asratian A; Holm L; Yngve A; Dantzer R; Heilig M; Hamilton JP; Samuelsson M
    Brain Behav Immun; 2022 Mar; 101():136-145. PubMed ID: 34999196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The kynurenine pathway in major depressive disorder under different disease states: A systematic review and meta-analysis.
    Ou W; Chen Y; Ju Y; Ma M; Qin Y; Bi Y; Liao M; Liu B; Liu J; Zhang Y; Li L
    J Affect Disord; 2023 Oct; 339():624-632. PubMed ID: 37467793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Systemic Inflammation Is Associated with Reduced Corticolimbic White Matter Integrity in Depression.
    Thomas M; Savitz J; Zhang Y; Burrows K; Smith R; Figueroa-Hall L; Kuplicki R; Khalsa SS; Taki Y; Teague TK; Irwin MR; Yeh FC; Paulus MP; Zheng H; On Behalf Of Tulsa Investigators
    Life (Basel); 2021 Dec; 12(1):. PubMed ID: 35054436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral activation therapy for depression is associated with a reduction in the concentration of circulating quinolinic acid.
    Savitz J; Ford BN; Yeh HW; Akeman E; Cosgrove K; Clausen AN; Martell C; Kirlic N; Santiago J; Teague TK; Irwin MR; Paulus MP; Aupperle RL
    Psychol Med; 2022 Oct; 52(13):2500-2509. PubMed ID: 33234171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between plasma tryptophan catabolites and depression: The role of symptom profiles and inflammation.
    Milaneschi Y; Allers KA; Beekman ATF; Giltay EJ; Keller S; Schoevers RA; Süssmuth SD; Niessen HG; Penninx BWJH
    Brain Behav Immun; 2021 Oct; 97():167-175. PubMed ID: 34252568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute administration of ibuprofen increases serum concentration of the neuroprotective kynurenine pathway metabolite, kynurenic acid: a pilot randomized, placebo-controlled, crossover study.
    Savitz J; Ford BN; Kuplicki R; Khalsa S; Teague TK; Paulus MP
    Psychopharmacology (Berl); 2022 Dec; 239(12):3919-3927. PubMed ID: 36271950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex- and suicide-specific alterations in the kynurenine pathway in the anterior cingulate cortex in major depression.
    Brown SJ; Christofides K; Weissleder C; Huang XF; Shannon Weickert C; Lim CK; Newell KA
    Neuropsychopharmacology; 2024 Feb; 49(3):584-592. PubMed ID: 37735504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Kynurenine Metabolism Pathway Activation in Major Depressive Disorders.
    Savitz J
    Curr Top Behav Neurosci; 2017; 31():249-267. PubMed ID: 27221627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.